Wei Jiang Selected Research

Wei Jiang Research Topics

Disease

542	Neoplasms (Cancer) 06/2024 - 05/2002
105	Inflammation (Inflammations) 03/2024 - 10/2002
84	Infections 03/2024 - 01/2008
63	Neoplasm Metastasis (Metastasis) 06/2024 - 05/2002
59	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 12/2003
58	Carcinogenesis 04/2024 - 12/2002
51	Fibrosis (Cirrhosis) 05/2024 - 10/2002
49	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 11/2005
45	Breast Neoplasms (Breast Cancer) 04/2024 - 10/2004
42	Hypoxia (Hypoxemia) 09/2023 - 08/2010
35	Pain (Aches) 03/2024 - 05/2008
32	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 10/2005
30	Adenocarcinoma 04/2024 - 10/2005
28	Nasopharyngeal Carcinoma 02/2024 - 03/2014
28	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 09/2002
27	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 06/2004
27	Lung Neoplasms (Lung Cancer) 06/2023 - 05/2003
25	Wounds and Injuries (Trauma) 04/2024 - 02/2007
25	Sepsis (Septicemia) 04/2024 - 05/2004
25	Heart Failure 12/2023 - 01/2002
24	Carcinoma (Carcinomatosis) 03/2024 - 05/2003
23	COVID-19 01/2024 - 01/2020
23	Body Weight (Weight, Body) 01/2023 - 07/2011
22	Atherosclerosis 05/2024 - 03/2007
22	Reperfusion Injury 03/2024 - 03/2008
22	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 06/2004
21	Disease Progression 06/2024 - 05/2009
21	Stroke (Strokes) 05/2024 - 07/2006
21	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 05/2014
21	Insulin Resistance 12/2023 - 12/2010
20	Neuroinflammatory Diseases 04/2024 - 10/2014
20	Obesity 02/2024 - 12/2010
18	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2008
18	Non-alcoholic Fatty Liver Disease 01/2024 - 06/2011
18	Necrosis 01/2023 - 10/2002
17	Hemorrhage 03/2024 - 03/2008
17	Glioma (Gliomas) 12/2023 - 03/2008
16	Hypertension (High Blood Pressure) 05/2024 - 02/2004
16	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 06/2017
16	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 02/2002
15	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2013
15	Rectal Neoplasms (Rectal Cancer) 03/2024 - 12/2012
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2024 - 10/2010
15	Chronic Hepatitis B 12/2023 - 01/2012
15	Neuralgia (Stump Neuralgia) 07/2023 - 01/2011
15	Adenocarcinoma of Lung 01/2023 - 06/2003
14	Brain Ischemia (Cerebral Ischemia) 04/2024 - 01/2012
14	Myocardial Infarction 04/2024 - 01/2002
14	Ischemia 02/2024 - 08/2005
14	Human Influenza (Influenza) 12/2023 - 09/2010
14	Cognitive Dysfunction 09/2023 - 08/2010

Drug/Important Bio-Agent (IBA)

164	Proteins (Proteins, Gene)FDA Link 07/2024 - 10/2002
83	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2011
81	MicroRNAs (MicroRNA)IBA 01/2024 - 09/2010
55	CytokinesIBA 04/2024 - 05/2005
47	Therapeutic UsesIBA 05/2024 - 01/2002
43	LipidsIBA 04/2024 - 08/2008
43	Messenger RNA (mRNA)IBA 11/2023 - 06/2003
42	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 12/2002
35	CollagenIBA 03/2024 - 04/2003
34	RNA (Ribonucleic Acid)IBA 03/2024 - 08/2005
34	EnzymesIBA 03/2024 - 01/2005
33	Long Noncoding RNAIBA 12/2023 - 04/2013
32	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 12/2010
31	InflammasomesIBA 04/2024 - 06/2013
27	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 08/2010
27	Transcription Factors (Transcription Factor)IBA 01/2023 - 11/2008
26	LigandsIBA 02/2024 - 05/2002
25	LipopolysaccharidesIBA 04/2024 - 04/2009
24	Peptides (Polypeptides)IBA 03/2024 - 02/2004
22	Oxygen (Dioxygen)IBA 01/2024 - 01/2012
22	Antiviral Agents (Antivirals)IBA 11/2023 - 10/2009
21	AntioxidantsIBA 03/2024 - 01/2016
20	AntigensIBA 05/2024 - 01/2011
20	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 05/2003
20	AntibodiesIBA 02/2024 - 01/2011
20	VaccinesIBA 01/2024 - 01/2012
19	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2024 - 06/2006
19	Immune Checkpoint InhibitorsIBA 05/2024 - 11/2019
19	AutoantibodiesIBA 10/2023 - 05/2012
18	Morphine (MS Contin)FDA LinkGeneric 10/2022 - 04/2009
17	CateninsIBA 05/2024 - 06/2012
17	Circular RNAIBA 01/2024 - 01/2019
16	CholesterolIBA 04/2024 - 08/2008
16	ProdrugsIBA 12/2023 - 12/2006
15	PlatinumIBA 12/2023 - 01/2009
15	Analgesics (Analgesic Drugs)IBA 07/2023 - 05/2008
15	Immunoglobulin G (IgG)IBA 01/2023 - 01/2019
15	Escitalopram FDA Link 09/2022 - 01/2012
14	oxidized low density lipoproteinIBA 04/2024 - 04/2003
14	AlbuminsIBA 01/2024 - 03/2008
14	Interleukin-6 (Interleukin 6)IBA 11/2023 - 08/2008
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 05/2003

Therapy/Procedure

277	Therapeutics 06/2024 - 05/2002
86	Drug Therapy (Chemotherapy) 07/2024 - 07/2011
63	Radiotherapy 03/2024 - 09/2010
28	Immunotherapy 06/2024 - 06/2019
23	Neoadjuvant Therapy 05/2024 - 01/2013
21	Chemoradiotherapy 02/2024 - 07/2011
14	Aftercare (After-Treatment) 04/2024 - 08/2010